Dianthus Therapeutics (DNTH) Preferred Shares Issued (2017)
Dianthus Therapeutics (DNTH) recorded quarterly Preferred Shares Issued of $2.0 million in Q3 2017, down 89.85% quarter-over-quarter from $19.7 million in Q2 2017.
Dianthus Therapeutics (DNTH) Preferred Shares Issued (2017) Analysis & Trends
Dianthus Therapeutics' Preferred Shares Issued history runs 1 years deep, the most recent figure standing at $2.0 million for Q3 2017.
- In Q3 2017, Preferred Shares Issued changed N/A year-over-year to $2.0 million; the TTM figure through Sep 2018 stood at $2.0 million (changed N/A YoY), while the FY2022 annual figure was $100.0 million, changed N/A from the prior year.
- Preferred Shares Issued was $2.0 million for Q3 2017 at Dianthus Therapeutics, down from $19.7 million in the prior quarter.
- In the past five years, Preferred Shares Issued ranged from a high of $19.7 million in Q2 2017 to a low of $2.0 million in Q3 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Dianthus Therapeutics | 3.60 Bn | 3.19 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2017 | 2.00 Mn |
| Sep 30, 2017 | 2.00 Mn |
| Jun 30, 2017 | 19.70 Mn |
| Jun 30, 2017 | 19.70 Mn |